674
Participants
Start Date
September 18, 2018
Primary Completion Date
October 2, 2019
Study Completion Date
October 2, 2019
Ertapenem
Antibiotic for complicated intra-abdominal infection
Sulopenem-Etzadroxil/Probenecid
Antibiotic for complicated intra-abdominal infection
Ciprofloxacin
Antibiotic for complicated intra-abdominal infection
Metronidazole
Antibiotic for complicated intra-abdominal infection
Amoxicillin-Clavulanate
Antibiotic for complicated intra-abdominal infection
Sulopenem
Antibiotic for complicated intra-abdominal infection
Medical Facility, Riga
Medical Facility, Gori
Medical Facility, Sofia
Medical Facility, Blagoevgrad
Medical Facility, Lom
Medical Facility, Plovdiv
Medical Facility, Plovdiv
Medical Facility, Kutaisi
Medical Facility, Rēzekne
Medical Facility, Daugavpils
Medical Facility, Pleven
Medical Facility, Rousse
Medical Facility, Kaposvár
Medical Facility, Pécs
Medical Facility, Veszprém
Medical Facility, Varna
Medical Facility, Varna
Medical Facility, Tallinn
Medical Facility, Tallinn
Medical Facility, Kohtla-Järve
Medical Facility, Columbus
Medical Facility, Columbus
Medical Facility, Royal Oak
Medical Facility, Tartu
Medical Facility, Butte
Medical Facility, St Louis
Medical Facility, Võru
Medical Facility, Omaha
Medical Facility, Lincoln
Medical Facility, Viljandi
Medical Facility, Idaho Falls
Medical Facility, Torrance
Medical Facility, Chula Vista
Medical Facility, Boston
Medical Facility, Somers Point
Medical Facility, Tbilisi
Medical Facility, Tbilisi
Medical Facility, Tbilisi
Medical Facility, Tbilisi
Medical Facility, Tbilisi
Medical Facility, Tbilisi
Medical Facility, Bielsk Podlaski
Lead Sponsor
Iterum Therapeutics, International Limited
INDUSTRY